Regulation 2026-09-09· RAPS
FDA Names New Deputy Commissioner for AI in Key Leadership Appointments
The U.S. Food and Drug Administration (FDA) has announced several key leadership appointments, including a new permanent deputy commissioner for technology and artificial intelligence. These appointments signify the agency's increasing focus on managing and regulating advanced technologies in the medical field.
Full write-up is being prepared. Meanwhile, see more coverage on the AI News feed.